Filing Details
- Accession Number:
- 0001209191-15-028370
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2015-03-20 19:49:42
- Reporting Period:
- 2015-03-18
- Filing Date:
- 2015-03-20
- Accepted Time:
- 2015-03-20 19:49:42
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1513818 | Versartis Inc. | VSAR | Pharmaceutical Preparations (2834) | 244106690 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1601948 | L Jeffrey Cleland | C/O Versartis, Inc. 4200 Bohannon Drive, Suite 250 Menlo Park CA 94025 | President And Ceo | Yes | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Disposition | 2015-03-18 | 1,124 | $20.03 | 99,487 | No | 4 | S | Direct | |
Common Stock | Disposition | 2015-03-19 | 1,315 | $20.01 | 98,172 | No | 4 | S | Direct | |
Common Stock | Disposition | 2015-03-20 | 740 | $20.07 | 97,432 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct |
Footnotes
- Shares sold pursuant to a 10b5-1 trading plan.
- The shares were sold at prices ranging from $20.00 to $20.11. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.
- The shares were sold at prices ranging from $20.00 to $20.02. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.
- The shares were sold at prices ranging from $20.01 to $20.17. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.